Endometriosis cannot be cured by using traditional Chinese medicine alone. The disease is mainly treated by western medical means such as hormonal agents and surgery, and Chinese medicine can only play a supplementary role through evidence-based treatment. The etiology and pathogenesis of endometriosis are not completely clear, and although it is a benign disease, its manifestation has a “malignant” biological behavior of erosion, metastasis and recurrence, which is complex in nature. The choice of treatment should be based on the patient’s age, fertility requirements, severity, location and extent of the lesion, as well as the family’s economic status, and individualized treatment should be given to different patients. Treatment is aimed at reducing and eliminating lesions, relieving and eliminating pain, improving and promoting fertility, and reducing and avoiding recurrence, and includes pharmacological and surgical treatment. Pharmacological treatment is to inhibit ovarian function, reduce the activity of lesions as well as adhesion formation, and is currently mostly sex hormone therapy. If the symptoms are not relieved after drug treatment, the local lesions are aggravated, or the fertility function is not restored, surgical treatment can be used, divided into surgery to preserve fertility, surgery to preserve ovarian function, and radical surgery, and for local ectopic lesions such as surgical scar sites and umbilicus, corresponding lesion excision should also be performed. The treatment of this disease has a high recurrence rate except for radical surgery. The recurrence rate is higher in patients with severe disease than in patients with mild disease, and the more severe the disease is, the faster the recurrence rate is. The annual recurrence rate is 5%-20%, and the 5-year cumulative recurrence rate is 40%, and after treatment with gonadotropin-releasing hormone agonists, the recurrence rate is 37% in patients with mild disease and 74% in patients with severe disease.